Stone Pharma Group (01093): SYS 6037 Injection (Monkeypox mRNA Vaccine) Approved for Clinical Trials in the USA

Zhuhai Finance APP news, Stone Pharmaceutical Group (01093) announced that the group's collaboration with the Institute of Microbiology, Chinese Academy of Sciences in the development of the preventive biological product, a Class 1 new drug SYS 6037 injection (monkeypox mRNA vaccine), has been approved by the U.S. Food and Drug Administration (FDA) for clinical trials in the United States.